GetTopicDetailResponse(id=d36711834e35, topicName=阿思尼布, introduction=, content=慢性髓細胞白血病 阿思尼布, image=null, comments=0, allHits=922, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon Aug 26 13:21:36 CST 2024, time=2024-08-26, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=494887, tagList=[TagDto(tagId=494887, tagName=阿思尼布)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2246615, encodeId=ac0122466158f, content=<a href='/topic/show?id=c52225680c6' target=_blank style='color:#2F92EE;'>#伊馬替尼#</a> <a href='/topic/show?id=9b5453e2447' target=_blank style='color:#2F92EE;'>#慢性髓性白血病#</a> <a href='/topic/show?id=d36711834e35' target=_blank style='color:#2F92EE;'>#阿思尼布#</a>, objectTitle=【JHO】伊馬替尼治療未達深度分子學反應的患者加入阿思尼布可改善反應, objectType=article, longId=858137, objectId=87bf85813e0f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401015/1728973098067_8538692.jpg, objectUrl=/article/show_article.do?id=87bf85813e0f, replyNumber=0, likeNumber=54, createdTime=2025-01-04, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87bf85813e0f, moduleTitle=【JHO】伊馬替尼治療未達深度分子學反應的患者加入阿思尼布可改善反應, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=87bf85813e0f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2231189, encodeId=02ff2231189a5, content=<a href='/topic/show?id=ccdf93951a7' target=_blank style='color:#2F92EE;'>#達沙替尼#</a> <a href='/topic/show?id=1c1e650e3c3' target=_blank style='color:#2F92EE;'>#潑尼松#</a> <a href='/topic/show?id=d36711834e35' target=_blank style='color:#2F92EE;'>#阿思尼布#</a> <a href='/topic/show?id=4d6412019408' target=_blank style='color:#2F92EE;'>#Ph+急性白血病#</a>, objectTitle=【Blood】阿思尼布、達沙替尼、潑尼松治療Ph+急性白血病的I期研究, objectType=article, longId=847092, objectId=dd6b84e09276, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401011/1728623442625_8538692.jpg, objectUrl=/article/show_article.do?id=dd6b84e09276, replyNumber=0, likeNumber=70, createdTime=2024-10-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=dd6b84e09276, moduleTitle=【Blood】阿思尼布、達沙替尼、潑尼松治療Ph+急性白血病的I期研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=dd6b84e09276)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2229224, encodeId=b4d52229224b0, content=<a href='/topic/show?id=c52225680c6' target=_blank style='color:#2F92EE;'>#伊馬替尼#</a> <a href='/topic/show?id=9b5453e2447' target=_blank style='color:#2F92EE;'>#慢性髓性白血病#</a> <a href='/topic/show?id=d36711834e35' target=_blank style='color:#2F92EE;'>#阿思尼布#</a>, objectTitle=【AJH】letter to editor：伊馬替尼仍是CML的最佳一線治療, objectType=article, longId=845814, objectId=f0b98458143f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240709/1720503969171_8538692.jpg, objectUrl=/article/show_article.do?id=f0b98458143f, replyNumber=0, likeNumber=167, createdTime=2024-10-04, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f0b98458143f, moduleTitle=【AJH】letter to editor：伊馬替尼仍是CML的最佳一線治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f0b98458143f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2222469, encodeId=1e39222246949, content=<a href='/topic/show?id=f22653e3211' target=_blank style='color:#2F92EE;'>#慢性髓細胞白血病#</a> <a href='/topic/show?id=d36711834e35' target=_blank style='color:#2F92EE;'>#阿思尼布#</a>, objectTitle=【Blood】諾華STAMP抑制劑阿思尼布治療初診慢性髓性白血病的ASCEND研究, objectType=article, longId=840522, objectId=9d5a84052287, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240718/1721284524390_8538692.jpg, objectUrl=/article/show_article.do?id=9d5a84052287, replyNumber=0, likeNumber=179, createdTime=2024-08-26, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9d5a84052287, moduleTitle=【Blood】諾華STAMP抑制劑阿思尼布治療初診慢性髓性白血病的ASCEND研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9d5a84052287)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-08-26發(fā)表于上海
